Ubs Group Ag Edwards Lifesciences Corp Call Options Transaction History

Ubs Group Ag

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$59.7 - $93.78 $895,500 - $1.41 Million	15,000 Added 20.0%	90,000 $5.94 Million
Q2 2024 Aug 13, 2024	BUY	$84.3 - $94.31 $2.53 Million - $2.83 Million	30,000 Added 66.67%	75,000 $6.93 Million
Q1 2024 May 13, 2024	SELL	$72.54 - $95.56 $2.18 Million - $2.87 Million	-30,000 Reduced 40.0%	45,000 $4.3 Million
Q4 2023 Feb 09, 2024	BUY	$61.71 - $77.76 $2.78 Million - $3.5 Million	45,000 Added 150.0%	75,000 $5.72 Million
Q3 2023 Nov 09, 2023	BUY	$69.28 - $93.38 $2.08 Million - $2.8 Million	30,000 New	30,000 $2.08 Million
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $1.99 Million - $2.27 Million	27,700 New	27,700 $6.46 Million

1,350

457M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.